Antioxidant Medical Cannabis Studies

• View All (505)

Cannabidiol and (?)?9-tetrahydrocannabinol are neuroprotective antioxidants (1998)

These data suggest that the non-psychotropic cannabinoid of natural origin CBD has therapeutic potential for the treatment of neurological oxidative disorders such as cerebral ischemia. View study
Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress (2011)

This review discusses recent research that states that CBD can contribute to the treatment of diseases and disorders such as rheumatoid arthritis, type I and II diabetes, atherosclerosis and Alzheimer’s disease. View study
Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure (2016)

In the chronic phase of epilepsy, post-treatment with cannabidiol could be considered as a protection mechanism of the temporal lobe, which improves the induction of the cellular autophagy pathway and antioxidant defense. View study
Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy (2014)

Cannabidiol prevents acute hepatic steatosis induced by alcohol in mice. The effective prevention of hepatic steatosis avoids the progressive damage caused by alcohol in the liver. View study
Neuroprotective antioxidants from marijuana ()

This research aimed to examine cannabidiol and other cannabinoids in cultures of cortical neurons of rats exposed to toxic levels of the neurotransmitter glutamate. It was found that using a system based on the cyclic reaction and a background reaction system, it was demonstrated that Cannabidiol THC and other cannabinoids are potent antioxidants. As evidence that cannabinoids can act as antioxidants in neuronal cultures, it was shown that cannabidiol reduces the toxicity of hydroperoxide in neurons. View study
Oxyradical Stress, Endocannabinoids, and Atherosclerosis (2015)

This research is based on the study of the possible role that endocannabinoids play in relation to the treatment of atherosclerosis and oxyradical stress. In addition to highlighting the role of reactive oxygen species (ROS) in intracellular signaling and the impact of deregulated signaling mediated by ROS in atherogenesis. View study
Prospects for cannabinoid therapies in basal ganglia disorders (2010)

Evidence has been found that supports the idea that cannabinoids that have antioxidant properties and / or the ability to activate receptors (CB2) may represent useful therapeutic tools in Parkinson’s disease (PD) and Huntington’s disease (HD). View study
Protective effects of ?9-tetrahydrocannabinol against N-methyl-D-aspartate-induced AF5 cell death (2005)

View study